Skip to main content
SpringerLink
Log in

Levosimendan

A Viewpoint by Wilbert S. Aronow

  • Adis New Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Aronow WS, Ahn C, Kronzon I. Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites. Am J Cardiol 1999; 84: 611–2

    Article  PubMed  CAS  Google Scholar 

  2. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure: the PROMISE Study Research Group. N Engl J Med 1991; 325: 1468–75

    Article  PubMed  CAS  Google Scholar 

  3. Packer M, Rouleau J, Swedberg K, et al. Effect of flosequinan on survival in chronic heart failure: preliminary results of the PROFILE study [abstract]. Circulation 1993; 88 (Suppl. I): 1–301

    Google Scholar 

  4. Uretsky BF, Jessup M, Konstam MA, et al. Multicenter trial of enoximone in patients with moderate to moderately severe congestive heart failure: lack of benefit compared with placebo. Circulation 1990; 82: 774–80

    Article  PubMed  CAS  Google Scholar 

  5. Cohn JN, Goldstein SO, Greenberg BH, et al. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. N Engl J Med 1998; 339: 1810–6

    Article  PubMed  CAS  Google Scholar 

  6. Follath F, Cleland JGF, Just H, et al. Efficacy and safety of intravenous levosimendan in severe low-output heart failure [abstract no. 3406]. Circulation 1999 Nov; 100 (18 Suppl.): 1–646

    Article  Google Scholar 

  7. Nieminen MS, Moiseyev VS, Andrejevs N, et al. Randomized study on safety and effectiveness of levosimendan in patients with left ventricular failure after an acute myocardial infarct [abstract no. 3404]. Circulation 1999; 100 (18 Suppl.): I–646

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mount Sinai School of Medicine, New York, New York, USA

    Wilbert S. Aronow

Authors
  1. Wilbert S. Aronow
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aronow, W.S. Levosimendan. Drugs 61, 628 (2001). https://doi.org/10.2165/00003495-200161050-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200161050-00007

Search

Navigation